192k views
3 votes
What is done with a patient's serum after an autoadsorption technique has been performed?

1) AlloAb's are identified
2) AutoAb is identified
3) The serum is discarded
4) AlloAb's are identified, and the serum can be used for compatibility testing

1 Answer

3 votes

Final Answer:

AlloAb's are identified, and the serum can be used for compatibility testing. Thus the correct option is (4).

Step-by-step explanation:

After performing an autoadsorption technique, the primary goal is to identify alloantibodies (AlloAb's) present in the patient's serum. Autoadsorption involves removing autoantibodies (AutoAb) by adsorbing them onto the patient's own red blood cells. Once this is achieved, the serum is left with potential alloantibodies that may have been masked by the presence of autoantibodies. The identification of alloantibodies is crucial for determining blood compatibility, especially in situations such as blood transfusions or organ transplants.Thus the correct option is (4).

The reason the serum is not discarded outright is that, if alloantibodies are detected, the serum can be used for compatibility testing. This involves cross-matching the patient's serum with potential donor blood to ensure a safe and compatible match. It is a critical step to prevent adverse reactions during transfusions or transplants. Discarding the serum would eliminate the opportunity to gather important information about the patient's antibody profile, which is essential for providing appropriate and safe medical care.

In summary, the autoadsorption technique aims to unmask alloantibodies by removing interfering autoantibodies. The serum is then utilized for identifying alloantibodies and subsequently employed in compatibility testing, ensuring the safest possible outcomes in medical interventions involving blood products or organ transplantation.

User Nick Vasic
by
8.3k points